232 related articles for article (PubMed ID: 18941229)
21. Myeloid cell receptor LRP1/CD91 regulates monocyte recruitment and angiogenesis in tumors.
Staudt ND; Jo M; Hu J; Bristow JM; Pizzo DP; Gaultier A; VandenBerg SR; Gonias SL
Cancer Res; 2013 Jul; 73(13):3902-12. PubMed ID: 23633492
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic upregulation of CCL2 and CCL3 via histone modifications in infiltrating macrophages after peripheral nerve injury.
Kiguchi N; Kobayashi Y; Saika F; Kishioka S
Cytokine; 2013 Dec; 64(3):666-72. PubMed ID: 24135048
[TBL] [Abstract][Full Text] [Related]
23. A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function.
Vallet S; Pozzi S; Patel K; Vaghela N; Fulciniti MT; Veiby P; Hideshima T; Santo L; Cirstea D; Scadden DT; Anderson KC; Raje N
Leukemia; 2011 Jul; 25(7):1174-81. PubMed ID: 21403648
[TBL] [Abstract][Full Text] [Related]
24. Dual role of CCL3/CCR1 in oral squamous cell carcinoma: implications in tumor metastasis and local host defense.
Silva TA; Ribeiro FL; Oliveira-Neto HH; Watanabe S; Alencar Rde C; Fukada SY; Cunha FQ; Leles CR; Mendonça EF; Batista AC
Oncol Rep; 2007 Nov; 18(5):1107-13. PubMed ID: 17914560
[TBL] [Abstract][Full Text] [Related]
25. CCL5, CCR1 and CCR5 in murine glioblastoma: immune cell infiltration and survival rates are not dependent on individual expression of either CCR1 or CCR5.
Pham K; Luo D; Liu C; Harrison JK
J Neuroimmunol; 2012 May; 246(1-2):10-7. PubMed ID: 22425022
[TBL] [Abstract][Full Text] [Related]
26. CCR5 deficiency aggravates crescentic glomerulonephritis in mice.
Turner JE; Paust HJ; Steinmetz OM; Peters A; Meyer-Schwesinger C; Heymann F; Helmchen U; Fehr S; Horuk R; Wenzel U; Kurts C; Mittrücker HW; Stahl RA; Panzer U
J Immunol; 2008 Nov; 181(9):6546-56. PubMed ID: 18941245
[TBL] [Abstract][Full Text] [Related]
27. MIP-1α/CCL3-mediated maintenance of leukemia-initiating cells in the initiation process of chronic myeloid leukemia.
Baba T; Naka K; Morishita S; Komatsu N; Hirao A; Mukaida N
J Exp Med; 2013 Nov; 210(12):2661-73. PubMed ID: 24166712
[TBL] [Abstract][Full Text] [Related]
28. CXCR3/CXCR3 ligand biological axis impairs RENCA tumor growth by a mechanism of immunoangiostasis.
Pan J; Burdick MD; Belperio JA; Xue YY; Gerard C; Sharma S; Dubinett SM; Strieter RM
J Immunol; 2006 Feb; 176(3):1456-64. PubMed ID: 16424173
[TBL] [Abstract][Full Text] [Related]
29. AMP-activated protein kinase activation mediates CCL3-induced cell migration and matrix metalloproteinase-2 expression in human chondrosarcoma.
Hsu CJ; Wu MH; Chen CY; Tsai CH; Hsu HC; Tang CH
Cell Commun Signal; 2013 Sep; 11():68. PubMed ID: 24047437
[TBL] [Abstract][Full Text] [Related]
30. Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis: lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the intestine.
Andres PG; Beck PL; Mizoguchi E; Mizoguchi A; Bhan AK; Dawson T; Kuziel WA; Maeda N; MacDermott RP; Podolsky DK; Reinecker HC
J Immunol; 2000 Jun; 164(12):6303-12. PubMed ID: 10843684
[TBL] [Abstract][Full Text] [Related]
31. CCR5 deficiency does not reduce hypertensive end-organ damage in mice.
Krebs C; Fraune C; Schmidt-Haupt R; Turner JE; Panzer U; Quang MN; Tannapfel A; Velden J; Stahl RA; Wenzel UO
Am J Hypertens; 2012 Apr; 25(4):479-86. PubMed ID: 22258337
[TBL] [Abstract][Full Text] [Related]
32. C-C motif chemokine CCL3 and canonical neutrophil attractants promote neutrophil extravasation through common and distinct mechanisms.
Reichel CA; Puhr-Westerheide D; Zuchtriegel G; Uhl B; Berberich N; Zahler S; Wymann MP; Luckow B; Krombach F
Blood; 2012 Jul; 120(4):880-90. PubMed ID: 22674804
[TBL] [Abstract][Full Text] [Related]
33. Leukocyte-specific CCL3 deficiency inhibits atherosclerotic lesion development by affecting neutrophil accumulation.
de Jager SC; Bot I; Kraaijeveld AO; Korporaal SJ; Bot M; van Santbrink PJ; van Berkel TJ; Kuiper J; Biessen EA
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):e75-83. PubMed ID: 23288165
[TBL] [Abstract][Full Text] [Related]
34. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium.
Yamagami S; Hamrah P; Miyamoto K; Miyazaki D; Dekaris I; Dawson T; Lu B; Gerard C; Dana MR
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1201-7. PubMed ID: 15790880
[TBL] [Abstract][Full Text] [Related]
35. The chemokine, CCL3, and its receptor, CCR1, mediate thoracic radiation-induced pulmonary fibrosis.
Yang X; Walton W; Cook DN; Hua X; Tilley S; Haskell CA; Horuk R; Blackstock AW; Kirby SL
Am J Respir Cell Mol Biol; 2011 Jul; 45(1):127-35. PubMed ID: 20870892
[TBL] [Abstract][Full Text] [Related]
36. MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells.
Oba Y; Lee JW; Ehrlich LA; Chung HY; Jelinek DF; Callander NS; Horuk R; Choi SJ; Roodman GD
Exp Hematol; 2005 Mar; 33(3):272-8. PubMed ID: 15730850
[TBL] [Abstract][Full Text] [Related]
37. Localization-Specific Expression of CCR1 and CCR5 by Mast Cell Progenitors.
Salomonsson M; Dahlin JS; Ungerstedt J; Hallgren J
Front Immunol; 2020; 11():321. PubMed ID: 32174921
[TBL] [Abstract][Full Text] [Related]
38. Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 alpha during differentiation of human monocytes to macrophages.
Kaufmann A; Salentin R; Gemsa D; Sprenger H
J Leukoc Biol; 2001 Feb; 69(2):248-52. PubMed ID: 11272275
[TBL] [Abstract][Full Text] [Related]
39. Protective role for CCR5 in murine lupus nephritis.
Turner JE; Paust HJ; Bennstein SB; Bramke P; Krebs C; Steinmetz OM; Velden J; Haag F; Stahl RA; Panzer U
Am J Physiol Renal Physiol; 2012 Jun; 302(11):F1503-15. PubMed ID: 22442210
[TBL] [Abstract][Full Text] [Related]
40. CCL3/MIP-1alpha is pro-inflammatory in murine T cell-mediated hepatitis by recruiting CCR1-expressing CD4(+) T cells to the liver.
Ajuebor MN; Hogaboam CM; Le T; Proudfoot AE; Swain MG
Eur J Immunol; 2004 Oct; 34(10):2907-18. PubMed ID: 15368307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
